Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Rubicon Research Ltd

NSE: RUBICON · BSE: 544578 · Pharmaceuticals & Biotechnology · 38 announcements

Share price
₹1,575.60
Market cap
₹26,081 Cr
Revenue (annual)
₹1,754 Cr
Net profit (annual)
₹246.7 Cr
P/E (TTM)
90.5×Sector 47.3×
Promoter holding
59.76%-0.10% QoQ
FII holding
7.52%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20:01 IST BSE
Merger & Restructuring

Rubicon Research Merger & Restructuring

Rubicon Research Limited announced the proposed merger of its wholly-owned subsidiary, Kia Health Tech Private Limited, into the company, seeking regulatory exemption under SEBI circulars.

15:30 IST NSE
Merger & Restructuring

Rubicon Research Merger & Restructuring Worth ₹27.84 Cr

Rubicon Research Limited's subsidiary acquired a manufacturing facility in New Jersey, USA, from InvaTech Pharma Solutions, LLC for an enterprise value of ₹27.84 Crore.

Value
₹27.84 Cr